II. Definitions
- Hemoptysis
- Massive Hemoptysis
- Functional diagnosis of critically ill patient with impaired airway or hemodynamic compromise
- Older criteria included expectoration of >100 ml of blood per 24 hours (or 50 ml in a single cough)
- Various volume criteria have been used ranging from 100 to 600 ml per 24 hours
- Life-Threatening Hemoptysis
- Hemoptysis AND
- Hemodynamic instability, abnormal gas exchange or need for urgent Resuscitation
III. Precautions
- Even small volumes of bright red blood (not simply blood tinged Sputum) may herald Massive Hemoptysis
- Evaluate carefully and consider early Endotracheal Intubation in high risk cases
- Patients with Hemoptysis die of asphyxiation, not Hemorrhage
IV. Epidemiology
- Incidence: 1 in 1000 patients per year
- Only 5-15% of hempotysis cases meet criteria for Massive Hemoptysis
- Massive Hemoptysis is associated with a 50% mortality rate
V. Pathophysiology: Arterial Sources of Bleeding
- See Hemoptysis Causes
-
Bronchial Artery (90%)
- Bronchial arteries are the primary arterial supply of intrapulmonary arteries
- Bronchial arteries anastomose with pulmonary arteries
- Pulmonary artery impaired flow (e.g. Pulmonary Embolism) shunts blood through Bronchial arteries
- Pulmonary Artery
- Pseudoaneurysms form in pulmonary arteries when adjacent lung parenchyma is chronically inflamed
- Chronic inflammation has many causes (e.g. Tb, cancer, Fungal Lung Infection, Lung Abscess)
- Non-Bronchial Systemic Artery
- Neovascularization and collateral circulation develops in response to chronic inflammation (see above)
- Affected vessels anastomose with fragile pulmonary vessels, which on rupture cause Hemoptysis
VI. History
- See Hemoptysis Causes
- Severity of Hemoptysis
- Past medical history
- Congestive Heart Failure
- Valvular heart disease
- Obstructive Lung Disease (e.g. COPD, Asthma, Bronchiectasis)
- Pulmonary Embolism Risk Factors (e.g. surgery, immobilization, travel, Estrogens, Family History)
- Cirrhosis or other Chronic Liver Disease
- Renal disease
- Personal or Family History of Bleeding Disorders (Coagulopathy, Thrombocytopenia)
- History or exposure to Tuberculosis (e.g. international travel to endemic regions)
- Cancer history
- Medications and toxins
- Anticoagulants (e.g. Warfarin, DOACs)
- Antplatelet Medications (e.g. Aspirin, Clopidogrel)
- Immunosuppression
- Tobacco Abuse (Lung Cancer, COPD, Bronchiectasis)
- Cocaine Inhalation
-
Cough
- Obstructive Lung Disease (e.g. Bronchiectasis, COPD, Asthma)
- Foreign Body Aspiration
- Infection (Acute Bronchitis, Pneumonia, Tuberculosis)
-
Fever
- Acute Bronchitis (most common cause)
- Pneumonia
- Lung Abscess
- Tuberculosis
- Pulmonary Embolism
- Lung Cancer
- Rheumatologic Disease
- Trauma
- Weight loss
- Travel or birth in endemic Tuberculosis regions
- Tuberculosis (U.S. Immigrants have 4 fold higher risk)
- Miscellaneous
- Other sites of bleeding (e.g. Hematuria, melana, Epistaxis, Menorrhagia)
VII. Exam
- Complete Vital Signs
- Examine for bleeding sources
- Oropharyngeal lesions or bleeding
- Epistaxis
- External Trauma to head, neck or chest
- Rectal Exam for black stool (upper gastrointestinal Hemorrhage)
- Examine for signs of Coagulopathy or other underlying Hemorrhage or inflammation risks
- Petechiae or Purpura
- Cirrhosis stigmata
- Cachexia
- Rheumatologic findings (e.g. synovitis, Cutaneous Signs of Rheumatic Disease)
- Hemoptysis
- Frothy Sputum with bright red blood, and alkaline pH
- Contrast with Hematemesis (coffee grounds with acidic pH)
- Findings suggestive of Massive Hemoptysis (respiratory or hemodynamic compromise)
- Dyspnea
- Tachypnea
- Increased work of breathing
- Wheezing
- Cyanosis
- Hypoxia
- Altered Mental Status
- Hypotension
- Tachycardia
VIII. Labs
- First-line studies
- Complete Blood Count with Platelets and differential
- ProTime (PT, INR)
- Partial Thromboplastin Time (aPTT)
- Blood Type and Cross-match (in Massive Hemoptysis)
- Comprehensive Metabolic Panel
- Sputum Gram Stain and culture
- Consider acid-fast bacilli, Fungal Culture, cytology
- Other studies to consider
- D-Dimer
- HIV Test
- Brain Natriuretic Peptide (BNP)
- Arterial Blood Gas or Venous Blood Gas
- Quantiferon-TB (or PPD)
- Does not replace Sputum testing when acute symptoms are present
- Electrocardiogram (EKG)
- Acute phase reactants (e.g. C-RP, ESR)
- Rheumatologic studies (e.g. ANCA, FANA, anticardiolipin, xGBM)
- Spirometry or Pulmonary Function Tests
- Do not perform in acute Hemoptysis (consider once stabilized)
IX. Imaging
-
Chest XRay
- First-line in most cases
-
Test Sensitivity for identifying bleeding site: 33%-82% (and identifies cause in 35% of cases)
- Findings include Pneumonia, cavitary lesions, Lung Abscess, Lung Mass, alveolar Hemorrhage
- Lower sensitivity for Lung Cancer (misses up to 10% of Bronchogenic Carcinomas in Hemoptysis)
-
Chest CT with Contrast indications (typically perform as CTA, with PE timed contrast)
- Test Sensitivity for detecting bleeding site
- Identify source of Hemoptysis to direct Intervention Radiology or surgery (Massive Hemoptysis)
- Mass lesion on Chest XRay
- Lung Cancer risk factors (e.g. Tobacco Abuse)
- Failed resolution of Pulmonary Infiltrate on Chest XRay
- Suspected Pulmonary Embolism
- Persistent symptoms despite negative Chest XRay
- Bronchoscopy indications
- Test Sensitivity for identifying bleeding site: 73-93% (and identifies cause in <8% of cases)
- CT chest non-diagnostic
- Mass lesion on Chest XRay
- Recurrent Hemoptysis
-
Bronchial artery arteriography
- Used in some cases when Intervention Radiology is planned for embolization
-
Echocardiogram
- Consider (esp. early POCUS) in the evaluation of cardiovascular cause (e.g. CHF)
- Consider other diagnostics if suspected Pseudohemoptysis
- Upper Endoscopy
- Nasopharyngoscopy
X. Differential Diagnosis
- See Hemoptysis Causes
- Distinguish from Pseudohemoptysis (e.g. upper respiratory or gastrointestinal source)
- Hemoptysis is with no known cause (cryptogenic) in 20 to 50% of cases
- Hemoptysis requiring acute emergent management is from Bronchial arteries in 90% of cases
XI. Evaluation: Non-Massive Hemoptysis
- See labs above
- Step 1: Consider non-lower respiratory cause (Pseudohemoptysis)
- Upper respiratory source (e.g. Sinusitis)
- Upper Gastrointestinal Bleeding (Hematemesis)
- Coffee grounds with acidic pH
- Step 2: Chest XRay
- See imaging as above
- Treat suspected causes based on initial findings
- Step 3: CT Chest or CTA Chest Indications
- Non-diagnostic history, exam, labs and chest x-ray
- High suspicion for serious underlying cause (e.g. Pulmonary Embolism, Trauma, cancer)
- Step 4: Bronchoscopy Indications
- See imaging above
XII. Management: Massive Hemoptysis
- See ABC Management
- Position patient with bleeding lung side down (if known source, e.g. Lung Lesion)
- Patient alert, not hypoxic and able to clear their own airway
- Supplemental Oxygen
- Avoid BIPAP or other positive pressure that interferes with airway clearance of blood
- Observe closely for decompensation
- Bronchial tree will completely fill with 150-200 cc of blood
-
Advanced Airway (patient decompensating, hypoxic)
- Attempt awake intubation under Ketamine
- Allows for visualization of cords as patient coughs and clears airway
- Large bore suction or suction via Endotracheal Tube attached to meconium aspirator
- Place as large a bore Endotracheal Tube as possible (e.g. >7.5 up to 8.5)
- Emergency Cricothyrotomy if unable to intubate
- Attempt awake intubation under Ketamine
- Imaging
- Obtain portable Chest XRay
- Obtain CT Chest or CTA Chest only when stable
-
Lung isolation
- Best performed by bronchoscopy if skilled operator available (e.g. pulmonology, thoracic surgery)
- Suspected source of Massive Hemorrhage is on the LEFT
- Pass the Endotracheal Tube into the right mainstem Bronchus (bleeding should stop)
- Suspected source of Massive Hemorrhage is on the RIGHT
- Pull ET Tube back to glottis (but still below Vocal Cords)
- Pass bougie (or bronchoscope) through ET Tube and rotate bougie 90 degrees left
- Pass ET Tube over the bougie and assess bleeding and position (auscultation, Chest XRay)
- Emergent Consultation
- Pulmonology Consultation for bronchoscopy
- Endobronchial lesion
- Source unknown
- Intervention Radiology for directed Bronchial artery embolization (Bronchial arteries are source in 90% of cases)
- Efficacy in control of Hemorrhage: >70%
- Indications
- Parenchymal bleeding identified
- Non-surgical candidate with vascular injury (e.g. Trauma)
- Refractory Hemorrhage despite bronchoscopy or thoracic surgery
- Recurrent bleeding risk
- Occurs in 10 to 58% of patients
- Median onset of rebleeding at 6-12 months (unlikely after 3 years)
- Rebleeding Risk Factors
- Aspergillosis
- Tuberculosis
- Cancer
- Severe Hemoptysis history
- Findings on bronchoscopy (blood clots or active bleeding)
- Cardiothoracic surgery Consultation
- Indicated in Hemorrhage following Chest Trauma or vascular injury
- Surgical Complications include perioperative bleeding, asphyxia, Bronchopleural Fistula
- High mortality risk
- Not actively bleeding: 2 to 18% mortality
- Active Hemoptysis: 25 to 50% mortality
- ECMO may be needed
- Pulmonology Consultation for bronchoscopy
- Manage Coagulopathy
- See Coagulation Bleeding Disorders
- See Emergent Reversal of Anticoagulation
- Consider Tranexamic Acid (TXA)
- References
- Swaminathan and Weingart in Herbert (2019) EM:Rap 19(3): 10-11
XIII. Management: Indications for ICU Admission or Tertiary Care Transfer
- Lesions at the highest risk of bleeding (e.g. Aspergillus infection, pulmonary artery involved)
- Respiratory distress or Hypoxia
- Respiratory Rate >30 per minute
- Oxygen Saturation <88% on room air
- Requiring High Flow Oxygen at >8 L/min or Mechanical Ventilation
- Hemodynamic instability
- Hemoglobin < 8 g/dl or more than 2 g/dl drop from baseline
- Disseminated Intravascular Coagulation (DIC) or other consumptive Coagulopathy
- Hypotension requiring intervention (fluid bolus, transfusion, Vasopressors)
- Massive Hemoptysis
- Hemoptysis >200 ml per 24 hours OR
- Hemoptysis >50 ml per 24 hours in a patient with COPD
- Serious comorbidity
- Previous pneumonectomy
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Ischemic Heart Disease
- References
XIV. Management: Non-Massive Hemoptysis
- See Evaluation above
- Consider antibiotic course if symptoms or signs of lower respiratory infection
- Consider Antitussive medications
- Serially re-evaluate
- Consider CT Chest
- Consider pulmonology Consultation for bronchoscopy
XV. Prognosis: Moderate to Severe Hemoptysis Mortality
- Criteria
- Score 1: Admit Chest XRay with involvement of 2 or more lung quadrants
- Score 1: Chronic Alcoholism
- Score 1: Pulmonary artery involvement
- Score 2: Aspergillosis
- Score 2: Malignancy
- Score 2: Mechanical Ventilation required
- Interpretation
- Admit to ICU for score >2 (see other indications above)
- Consider urgent Intervention Radiology for score >5
- Mortality: In-Hospital
- Total 0: Mortality 1%
- Total 1: Mortality 2%
- Total 2: Mortality 6%
- Total 3: Mortality 16%
- Total 4: Mortality 34%
- Total 5: Mortality 58%
- Total 6: Mortality 79%
- Total 7: Mortality 91%
- References
XVI. Prognosis: Mild Hemoptysis
- Mortality: 0.3%
- Recurrence in 19% of patients (73% rebleed in first 2 years)
- Risks for recurrent bleeding
- Aspergillosis
- Nontuberculous Mycobacterium infection
- Smoking
- Findings on bronchoscopy (blood clots or active bleeding)
- References
- Choi (2018) Am J Emerg Med 36(7): 1160-5